Berlin-Buch. The health location.

Berlin-Buch

For one hundred years, physicians and researchers collaborating at Berlin-Buch have been devoted to advancing health.
Here you are invited to learn about Berlin-Buch and its partners and to become acquainted with the unique atmosphere of the campus where the medicine of the future is being created. 

Berlin-Buch – dedicated to health

Outstanding hospitals and excellent achievements in basic biomedical research have long been hallmarks of Berlin-Buch. The internationally renowned location for science and health care provision is one of the major players in the health industry cluster in the capital city region.

In line with its clear focus on biomedicine, the Berlin-Buch location offers life science companies and research institutions unique conditions for synergies and for value creation networks. Here clinicians and basic researchers collaborate in joint projects to apply new insights gained in the high-tech laboratories to patient care. New discoveries are available to patients at Berlin-Buch already in the stage of clinical trials.

The promotion and preservation of health is the overarching goal of the circa 6500 people who work at Berlin-Buch – among them scientists of world renown, highly motivated physicians, teachers in the health professions and innovative entrepreneurs.

News Buch Berlin

Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) has received from the Berlin City Government a 66-year long-term lease for an industrial property with 53,000 square feet (...

more ...

Lighting up tumor cells

MDC PhD student Matthias Jürgen Schmitt is being honored with the Curt Meyer Memorial Prize of the Berlin Cancer Society for his achievements in cancer research. He employs molecular reporters to inve...

more ...

Nantes University Hospital Doses First Patients with Eckert & Ziegler’s Novel Ga-68 Imaging Agent PENTIXAFOR

PENTIXAFOR is an innovative imaging compound for the initial staging of cancer patients with symptomatic multiple myelomas. The Ga-68 based radio-diagnostic promises to significantly improve the patie...

more ...

Events Buch Berlin

08.11.2021, 09:00
Weiterbildungskurs: Fachkraft für Molekularbiologie (TÜV) vom 8. - 19. November 2021

Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung. Nutzen Sie auch die Gele...

more ...

09.11.2021, 16:00
Vortrag: "SARS-Cov-2-Forschung: Zellveränderungen bei Infektion und daraus entstehende unterschiedliche Krankheitsverläufe"

Referent: Dr. Emanuel Wyler, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC)/BIMSB

more ...

22.11.2021, 15:00
VORLESUNGSREIHE "NEUE WEGE IN DER BIOMEDIZIN": Neues aus der Hirnforschung

Themen sind Esssörungen und Multiple Sklerose

more ...

This website is supported by: